Why the study?
Does short-term high-dose combination oral antioxidant supplementation reduce blood pressure in hypertensive and normotensive outpatients?
Does short-term high-dose combination oral antioxidant supplementation reduce blood pressure in hypertensive and normotensive outpatients?
Short-term high-dose combination oral antioxidant therapy reduces systolic blood pressure in outpatients, particularly those with treated hypertension.
Answers are grounded in this paper and cite their sources.
Short-term antioxidant supplementation may lower SBP in treated hypertensives; extends RCT evidence for adjunctive BP reduction.
Hypertension affects 30% of adults and low intakes of antioxidants have been associated with increased risk of hypertension and cardiovascular disease. To investigate the effect of short-term high-dose antioxidant supplementation on blood pressure in hypertensive and normotensive outpatients, we undertook a randomized, double-blind, crossover design placebo-controlled study. 2. Forty subjects were recruited from medical outpatient clinics, of whom 38 completed the study. Twenty-one were attending for treatment of hypertension and 17 were normotensive, attending for minor gastrointestinal complaints. Subjects were randomly assigned to receive either 8 weeks placebo followed by 2 weeks washout then 8 weeks antioxidants or vice versa. The combination of antioxidants consisted of 200 mg of zinc sulphate, 500 mg of ascorbic acid, 600 mg of alpha-tocopherol (sodium succinate salt) and 30 mg of beta-carotene daily. 3. Systolic blood pressure fell at the end of the antioxidant phase compared with the placebo phase both in subjects receiving anti-hypertensive therapy (P < 0.01) and those who were normotensive (P = 0.067). Circulating levels of beta-carotene and alpha-tocopherol increased in all subjects during supplementation (P < 0.01) and urine nitrite increased in hypertensive patients (P < 0.05). 4. Short-term oral high-dose combination antioxidant therapy reduces blood pressure, possibly via increased availability of nitric oxide. This study may have implications for the innovative use of antioxidants as an adjunct to anti-hypertensive therapy.
No takes yet. Share an insight, caveat, or question.
Galley et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: